View in EDS

A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure.

Saved in:
Bibliographic Details
Title: A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure.
Authors: Thepot, Sylvain1, Boehrer, Simone2, Seegers, Valérie3, Prebet, Thomas4, Beyne-Rauzy, Odile5, Wattel, Eric6, Delaunay, Jacques7, Raffoux, Emmanuel8, Hunault, Mathilde1, Jourdan, Eric9, Chermat, Fatiha10, Sebert, Marie10, Kroemer, Guido11, Fenaux, Pierre10, Adès, Lionel10 lionel.ades@avc.aphp.fr
Source: Leukemia Research. Dec2014, Vol. 38 Issue 12, p1430-1434. 5p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first